Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Los Alamitos CA, Las Vegas NV, Chandler AZ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Los Angeles CA, Palm Springs CA, San Diego CA,
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for
HER2-positive Breast Cancer, Breast Cancer
Location: Los Alamitos CA, Long Beach CA, Albuquerque NM,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07102381
Phase2, Recruiting
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Get alerts for new trials in your area by subscribing now
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Los Alamitos CA, Los Angeles CA, Santa Monica CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase3, Recruiting
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Duarte CA, Houston TX, Chicago IL, Grand Rapids MI,
Sponsor: Debiopharm International SA
Sex: All
Age: 18+
Code: NCT06969430
Phase1, Phase2, Recruiting
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
for
High-risk Myelodysplastic Syndrome,
Location: Duarte CA, Palo Alto CA, Houston TX, St Louis MO,
Sponsor: Crossbow Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT06994676
Phase1, Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
for
T-cell-prolymphocytic Leukemia,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06810778
Phase1, Phase2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Los Alamitos CA, Torrance CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
Ivonescimab for the Treatment of Thymic Cancer
for
Thymus Carcinoma
Location: Los Angeles CA, San Francisco CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06980077
Phase2, Recruiting
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
for
TNBC - Triple-Negative Breast Cancer, Breast Cancer
Location: Los Angeles CA
Sponsor: Stephen Shiao
Sex: Female
Age: 18+
Code: NCT05491226
Phase2, Recruiting
Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
for
Hematopoietic and Lymphatic System Neoplasm
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07025538
Phase1, Recruiting
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
for
Nausea and Vomiting, Obesity
Location: Los Angeles CA, San Diego CA, Tampa FL
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07446439
Phase3, Recruiting
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
for
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,
Location: Los Alamitos CA, Los Angeles CA, Houston TX, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06501625
Phase1, Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Los Alamitos CA, Torrance CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus,
Location: La Palma CA, San Antonio TX, Irving TX, Clearwater FL,
Sponsor: DualityBio Inc.
Sex: All
Age: 18 - 70
Code: NCT06625671
Phase1, Phase2, Recruiting
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors